Total Reports
93,675
Highest-reported breed
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for Retriever - Labrador (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.
By recorded gender -- every report on file for Retriever - Labrador, no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Retriever - Labrador is #1 of 510 by total reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Retriever - Labrador has 93,675 reports now versus 92,460 in that prior snapshot: 1,215 more (1.3%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Retriever - Labrador changesTotal Reports
93,675
Highest-reported breed
Deaths Reported
3,463
of 93,675 reports
Death-coded share of reports
3.7%
Below-median death-coded share
Avg Age at Report
5.2 yr
30.8 kg avg weight
A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.
Share of reports coded as a fatality
Share of reports resulting in euthanasia
Share of reports coded "Recovered/Normal"
Change in annual report volume over the last 5 complete years
3.7% of 93,675 retriever - labrador reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Every breed shown has at least 50 filed reports. Volume reflects how often a breed is reported, not how common it is; death rate is the share of a breed's own reports coded as a death outcome.
| Year | Reports | Trend |
|---|---|---|
| 2010 | 3,617 | |
| 2011 | 3,906 | |
| 2012 | 5,248 | |
| 2013 | 5,940 | |
| 2014 | 6,189 | |
| 2015 | 6,509 | |
| 2016 | 6,916 | |
| 2017 | 6,945 | |
| 2018 | 6,559 | |
| 2019 | 6,435 | |
| 2020 | 5,958 | |
| 2021 | 5,586 | |
| 2022 | 5,129 | |
| 2023 | 5,339 | |
| 2024 | 6,680 | |
| 2025 | 5,810 | |
| 2026 | 909 | |
Signature read: 93,675 reports place Retriever - Labrador in the upper third of breed filing volume (#1 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Retriever - Labrador sits at #1 of 510 by report volume among all breeds and #1 of 298 among dog breeds, with 93,675 reports and 3,463 (3.7%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #195 of 275. Mean age at report: 5.2 years, average weight 30.8 kg (67.9 lbs).
Top reported signs: Vomiting (15,717), Lack of efficacy (endoparasite) - heartworm (10,620), INEFFECTIVE, HEARTWORM LARVAE (9,664). Most-referenced drug: Milbemycin Oxime + Spinosad (16,527 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (14,916) and Pyrantel Pamoate;Sarolaner (5,981).
Outcome coding on 87,199 status-recorded reports is dominated by Outcome Unknown (34.3%). Annual submissions ranged 909-2,026 across 17 years on file.
Retriever - Labrador is a high-volume FDA CVM cohort (93,675 reports) - enough filings to measure how concentrated the reaction and drug mix is, not just the headline totals. Across 20 named reaction terms in the stored top list, the leading three (Vomiting, Lack of efficacy (endoparasite) - heartworm, INEFFECTIVE, HEARTWORM LARVAE) account for 37.3% of listed reaction mentions. The Herfindahl index on that list is 0.077 (1.0 = a single reaction owns every mention; lower = a broader clinical mix).
On the drug side, 20 referenced products appear in the top list; the leading three (Milbemycin Oxime + Spinosad, Ivermectin + Pyrantel As Pamoate Salt, Pyrantel Pamoate;Sarolaner) cover 44.4% of those mentions. That multi-product footprint is the profile thin-report breeds cannot show - their pages stop at a short bar list because the sample cannot support a concentration read.
Outcome coding on 87,199 status-recorded filings splits roughly 4.0% severe (died or euthanized - 3,469 reports) versus 34.0% recovered or recovered-with-sequela (29,675). Read that split next to the 3.7% death-coded share above - both track reporting severity bias in a popular breed, not a proven mortality rate.
Peak filing year was 2017 (6,945 reports); the lightest year on file was 2026 (909). From 2024 to 2025, annual volume fell 13.0% (6,680 → 5,810). Year-to-year swings at this volume usually track product launches, owner awareness, and reporting campaigns more than sudden breed-health shocks.
Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.
High-volume peer sets for Retriever - Labrador drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds with ≥50 reports (3.7% death-coded here).
Nearest other-species breeds by reported average weight (30.8 kg here).
What to do with this dog
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →